Use this URL to cite or link to this record in EThOS:
Title: A study of salivary glands and saliva in health and disease.
Author: Mason, Gillian Ivy.
ISNI:       0000 0001 3620 7036
Awarding Body: University of Birmingham
Current Institution: University of Birmingham
Date of Award: 2001
Availability of Full Text:
Access from EThOS:
Much of this thesis describes the use of immunohistochemical methods on salivary glands from patients with Sjogren's syndrome (SS) to quantify the position, nature and proliferative activity of the inflammatory cell infiltrate, deposition of cell matrix proteins and glandular expression of TGFp. Studies are also undertaken on glands from an experimental animal model and from patients with two associated conditions, benign lymphoepithelial lesion (BLEL) and systemic sclerosis (SSc). Initially a rat model of SS was examined and changes in salivary glands quantified at different stages after autoimmunisation. Immunohistochemically there were similarities to SS, in that class II antigen was expressed by glandular epithelium and the early lesions contained T lymphocytes. However, B lymphocytes were rare, the cell infiltrate contained large populations of macrophages and neutrophils, and there was evidence of increased elaboration of fibrous connective tissue. These results indicate that this animal model is of doubtful use for the study of Sjogren's syndrome. Studies on human tissue showed that the lymphocyte infiltrate in BLEL patients was more extensive than SS and that T cells predominated in small foci, whereas B cells were the dominant lymphocyte type in larger foci. In areas of extensive lymphocyte infiltration, B cells were closely associated with ducts or present in germinal centre-like structures with T cells being found elsewhere. A previously unreported feature of BLEL was the presence of intra-epithelial (and intra-lumenal) B cells, many of which were proliferating. The remaining duct walls in BLEL appeared to be under pressure due to this population of B lymphocytes and "holes" were observed both in the basement membrane and at the lumenal surface that may facilitate migration of lymphocytes from glandular stroma into duct lumens. There was significantly more tenascin and fibronectin in BLEL glands (p<0.01) compared to normal parotid controls which contained minimal amounts of these proteins. By contrast, both proteins were expressed in normal labial glands with no significant increase in glands from SS and SSc patients. As both tenascin and fibronectin are important in cell migration, increased levels may be a factor facilitating lymphoid infiltration in BLEL. Absorbance measurements demonstrated that ductal expression of TGFI differed between control, SS and BLEL salivary glands. SS glands showed an increase in expression of all isoforms of TGFß with the increase for TGFP2 and TGFP3 being significant (p=0.02 & p<0.002). By contrast, ductal expression of all isoforms of TGFI in BLEL was reduced in both confluent (p<0.0001) and minimally infiltrated (p<0.005) areas of gland. Thus reduced glandular expression of TGFJ may be important in allowing the high levels of lymphocyte and epithelial cell proliferation detected in BLEL which are rarely seen in SS. Salivary glands from SSc and Raynaud's phenomenon (RP) patients contained small, predominately T cell foci with few proliferating B cells and a significantly increased mast cell population (p<0.005). Fibrosis within the glands was variable and not associated with increased deposition of fibronectin or tenascin. Subjectively, the most obvious difference in TGFI expression in SSc compared to controls was exhibited by fibroblasts. Cell counts revealed no differences in fibroblast expression of TGFßI or TGFß receptors. However, the percentage of TGFß2-positive fibroblasts was significantly higher in SSc glands compared to controls (p<0.004). RP glands showed an intermediate level of expression. By contrast, a lower percentage of RP fibroblasts expressed TGF(33 compared to controls, with SSc glands showing an intermediate level of expression. The results indicate that both SSc and RP are associated with an increased salivary gland mast cell population and changes in expression of TGFß2 and ß3 isoforms by glandular fibroblasts. The final section of this thesis describes an investigation of antioxidant levels in saliva from healthy individuals and patients with SS or periodontal disease. The results demonstrated that in SS there was an increase in the concentration of antioxidants in unstimulated saliva but a reduced rate of production. This diminished output of salivary gland antioxidants may be of significance to the oral health of these patients. In periodontal disease there was a reduction in antioxidant levels in stimulated saliva that may have been the result of local depletion by reactive oxygen species, produced by chronic inflammation within the gingival tissues. Alternatively, these patients may have intrinsically reduced levels of antioxidants and therefore be more susceptible to periodontal disease.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID:  DOI: Not available
Keywords: Sjogren's syndrome; Immunohistochemistry; Systemic sclerosis